Table 2 Characteristics of included guidelines and one statement
country | Issueing organization | name of guideline | initial release | revisions | target patients | target users/setting | evidence base | grading of evidence | ||
|---|---|---|---|---|---|---|---|---|---|---|
LoE | GoR | |||||||||
CEBAM | Belgium | Belgian Centre for Evidence Based Medici, Cochrane Belgium | Chronische Niereninsufficiëntie | 2012 | adult patients (over 18 years of age) with chronically diminished kidney function | general practitioners | systematic guideline review, additional systematic searches | GRADE | ||
ACP | USA | American College of Physicians | Screening, Monitoring, and Treatment of Stage 1 to 3 Chronic Kidney Disease: A Clinical Practice Guideline From the American College of Physicians | 2013 | target patient population for screening is adults, and the target population for treatment it is adults with stage 1 to 3 CKD | clinicians | systematic review | American College of Physicians grading system, adapted from GRADE | ||
HAS | France | Haute Autorité de Santé | Guide de parcours de soins Maladie Rénale Chronique de l’adulte | 2012 | Adult patients with chronic kidney disease. Excluded: patients with end stage renal disease, dialysis or transplantation, inpatients. | General practitioners, dieticians, nurses, pharmacists, etc., and may also concern other health professionals (Nephrologists, cardiologists, diabetologists, physiotherapists, psychologists) | unclear, existing recommendations, expert opinion | no formal grading of evidence or level of recommendation | ||
KDIGO | USA | Kidney Disease Improving Global Outcomes | KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease | 2012 | individuals at risk for or with CKD | Providers: Nephrologists (adult and pediatric), dialysis providers(including nurses), Internists, and pediatricians.patients: Adult and pediatric individuals at risk for or with CKD. Policy Makers: Those in related health fields. | systematic review | GRADE | ||
KHA-CARI | Australia, New Zealand | Kidney Health Australia, Caring for Australasians with Renal Impairment | Early Chronic Kidney Disease | 2013 | patients with kidney disease in Australia & New Zealand, patients with early chronic kidney disease | clinicians and health care workers | systematic review | GRADE | ||
BCMA | Canada | British Columbia Medical Association | Chronic Kidney Disease - Identification, Evaluation and Management of Adult Patients | 2014 | adults aged ≥19 years at risk of or with known chronic kidney disease | The primary audience for BC Guidelines is British Columbia physicians, nurse practitioners, and medical students. However, other audiences such as health educators, health authorities, allied health organizations, pharmacists, and nurses may also find them to be a useful resource | not described | no formal grading of evidence or level of recommendation | ||
UMHS | USA | University of Michigan Health System | Management of Chronic Kidney Disease | 2005 | Interim/minor revision: March, 2014 June, 2016 | adults with chronic kidney disease | clinicians, primary care poviders | systematic review | GRADE, not formally stated | |
VA-DoD | USA | Department of Veterans Affairs, Department of Defense | VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care | 2014 | – | adults 18 years or older with CKD 1–4 without kidney transplant | primary care providers | systematic review | GRADE | |
NICE | UK | National Institute of Health and Care Excellence | Early identification and management of chronic kidney disease in adults in primary and secondary care | 2014 | Update 2015 | Adults 18+ with or at risk of developing chronic kidney disease | Healthcare professionals Commissioners and providers People with chronic kidney disease and their families and carers | systematic review | NICE | |
USPSTF | USA | United States Preventive Services Task Force | Final Recommendation statement, Chronic Kidney Disease: Screening | 2012 | asymptomatic adults without diagnosed CKD | clinicians | probably systematic review “The USPSTF reviewed evidence on screening for CKD, including evidence on screening, accuracy of screening, early treatment, and harms of screening and early treatment.” | one recommendation, not graded | ||